[The 43rd Report on the Survey of Adverse Reactions to Radiopharmaceuticals (46th Survey in 2020)].
adverse reactions
defective products
radiopharmaceuticals
Journal
Kaku igaku. The Japanese journal of nuclear medicine
ISSN: 2189-9932
Titre abrégé: Kaku Igaku
Pays: Japan
ID NLM: 2985202R
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
24
3
2022
pubmed:
25
3
2022
medline:
26
3
2022
Statut:
ppublish
Résumé
This survey was performed to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2020 in Japan. The results are based on responses to questionnaires sent to nuclear medicine centers. Replies were obtained from 1,006 centers out of 1,212 to which the questionnaire was sent. A total of 940,758 administrations of radiopharmaceuticals were reported. There were 17 cases with adverse reactions, giving an incidence of adverse reactions of 1.8 per 100,000 cases. Two cases of defective products were reported, giving an incidence of defective products of 0.2 per 100,000 cases.
Identifiants
pubmed: 35321966
doi: 10.18893/kakuigaku.rp.2231
doi:
Substances chimiques
Radiopharmaceuticals
0
Types de publication
Journal Article
Langues
jpn
Sous-ensembles de citation
IM